160 related articles for article (PubMed ID: 36346023)
1. Minor red blood cell antigen phenotyping of athletes sampled in international competitions.
Cristina Mirotti L; Renovato-Martins M; Du Rocher-Silva B; Dudenhoeffer-Carneiro AC; Soares F; Rahaman KA; Hasan M; Muresan AR; Kwon OS; Son JJ; Pereira HMG
Drug Test Anal; 2023 Mar; 15(3):292-298. PubMed ID: 36346023
[TBL] [Abstract][Full Text] [Related]
2. Possible cause of lack of positive samples on homologous blood transfusion.
Krotov G; Nikitina M; Rodchenkov G
Drug Test Anal; 2014; 6(11-12):1160-2. PubMed ID: 25331764
[TBL] [Abstract][Full Text] [Related]
3. Blood transfusions in athletes. Old dogmas, new tricks.
Lippi G; Banfi G
Clin Chem Lab Med; 2006; 44(12):1395-402. PubMed ID: 17163813
[TBL] [Abstract][Full Text] [Related]
4. Autologous Doping with Cryopreserved Red Blood Cells - Effects on Physical Performance and Detection by Multivariate Statistics.
Malm CB; Khoo NS; Granlund I; Lindstedt E; Hult A
PLoS One; 2016; 11(6):e0156157. PubMed ID: 27284981
[TBL] [Abstract][Full Text] [Related]
5. Blood doping in athletes--detection of allogeneic blood transfusions by flow cytofluorometry.
Arndt PA; Kumpel BM
Am J Hematol; 2008 Aug; 83(8):657-67. PubMed ID: 18508326
[TBL] [Abstract][Full Text] [Related]
6. The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs.
Negro F; Di Trana A; Marinelli S
Acta Biomed; 2022 Jan; 92(6):e2021401. PubMed ID: 35075058
[TBL] [Abstract][Full Text] [Related]
7. Scientific and forensic standards for homologous blood transfusion anti-doping analyses.
Giraud S; Robinson N; Mangin P; Saugy M
Forensic Sci Int; 2008 Jul; 179(1):23-33. PubMed ID: 18514452
[TBL] [Abstract][Full Text] [Related]
8. Detection of autologous blood transfusions in athletes: a historical perspective.
Mørkeberg J
Transfus Med Rev; 2012 Jul; 26(3):199-208. PubMed ID: 22119492
[TBL] [Abstract][Full Text] [Related]
9. Investigation on the application of DNA forensic human identification techniques to detect homologous blood transfusions in doping control.
Donati F; Stampella A; de la Torre X; Botrè F
Talanta; 2013 Jun; 110():28-31. PubMed ID: 23618171
[TBL] [Abstract][Full Text] [Related]
10. Blood transfusion in sports.
Giraud S; Sottas PE; Robinson N; Saugy M
Handb Exp Pharmacol; 2010; (195):295-304. PubMed ID: 20020370
[TBL] [Abstract][Full Text] [Related]
11. Whispers in the Blood: Leveraging MicroRNAs for Unveiling Autologous Blood Doping in Athletes.
Hassanpour M; Salybekov AA
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203416
[TBL] [Abstract][Full Text] [Related]
12. Proof of homologous blood transfusion through quantification of blood group antigens.
Nelson M; Popp H; Sharpe K; Ashenden M
Haematologica; 2003 Nov; 88(11):1284-95. PubMed ID: 14607758
[TBL] [Abstract][Full Text] [Related]
13. Doping in sport: a review of elite athletes' attitudes, beliefs, and knowledge.
Morente-Sánchez J; Zabala M
Sports Med; 2013 Jun; 43(6):395-411. PubMed ID: 23532595
[TBL] [Abstract][Full Text] [Related]
14. Clean Olympians? Doping and anti-doping: the views of talented young British athletes.
Bloodworth A; McNamee M
Int J Drug Policy; 2010 Jul; 21(4):276-82. PubMed ID: 20056401
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin and blood doping.
Robinson N; Giraud S; Saudan C; Baume N; Avois L; Mangin P; Saugy M
Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i30-4. PubMed ID: 16799100
[TBL] [Abstract][Full Text] [Related]
16. Blood doping: risks to athletes' health and strategies for detection.
Oliveira CD; Bairros AV; Yonamine M
Subst Use Misuse; 2014 Jul; 49(9):1168-81. PubMed ID: 24766400
[TBL] [Abstract][Full Text] [Related]
17. Autologous Blood Transfusion in Sports: Emerging Biomarkers.
Salamin O; De Angelis S; Tissot JD; Saugy M; Leuenberger N
Transfus Med Rev; 2016 Jul; 30(3):109-15. PubMed ID: 27260108
[TBL] [Abstract][Full Text] [Related]
18. Detecting Autologous Blood Transfusion in Doping Control: Biomarkers of Blood Aging and Storage Measured by Flow Cytofluorimetry.
Donati F; Acciarini R; De Benedittis I; de la Torre X; Pirri D; Prete M; Stampella A; Vernucci E; Botre F
Curr Pharm Biotechnol; 2018; 19(2):124-135. PubMed ID: 29621963
[TBL] [Abstract][Full Text] [Related]
19. Doping Prevalence in Competitive Sport: Evidence Synthesis with "Best Practice" Recommendations and Reporting Guidelines from the WADA Working Group on Doping Prevalence.
Gleaves J; Petróczi A; Folkerts D; de Hon O; Macedo E; Saugy M; Cruyff M
Sports Med; 2021 Sep; 51(9):1909-1934. PubMed ID: 33900578
[TBL] [Abstract][Full Text] [Related]
20. Current strategic approaches for the detection of blood doping practices.
Segura J; Ventura R; Pascual JA
Forensic Sci Int; 2011 Dec; 213(1-3):42-8. PubMed ID: 21889274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
